Abundant circulating lipids — a new opportunity for NSCLC detection?

Markus R. Wenk; Hyungwon Choi

doi:10.1038/s41571-022-00621-5

Abundant circulating lipids — a new opportunity for NSCLC detection?

Markus R. Wenk^*
, Hyungwon Choi^*

^*Corresponding author for this work

National University of Singapore

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

Abstract

Non-small-cell lung cancer (NSCLC) is a growing public-health threat, with one of the highest mortality risks among non-communicable diseases. Now, researchers have developed a diagnostic tool for NSCLC by mass spectrometry of a targeted panel of lipids. Herein, we discuss key aspects that could facilitate the clinical implementation of this and similar tools in other fields of application.

Original language	English
Pages (from-to)	361-362
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	19
Issue number	6
DOIs	https://doi.org/10.1038/s41571-022-00621-5
Publication status	Published - Jun 2022
Externally published	Yes

Access to Document

10.1038/s41571-022-00621-5

Cite this

@article{c58e049371884e60ae2b088099671991,

title = "Abundant circulating lipids — a new opportunity for NSCLC detection?",

abstract = "Non-small-cell lung cancer (NSCLC) is a growing public-health threat, with one of the highest mortality risks among non-communicable diseases. Now, researchers have developed a diagnostic tool for NSCLC by mass spectrometry of a targeted panel of lipids. Herein, we discuss key aspects that could facilitate the clinical implementation of this and similar tools in other fields of application.",

author = "Wenk, \{Markus R.\} and Hyungwon Choi",

year = "2022",

month = jun,

doi = "10.1038/s41571-022-00621-5",

language = "English",

volume = "19",

pages = "361--362",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",